ATR is a high-affinity specific inhibitor of ANT; the depletion or chemical inhibition of ANT2 improves the liver steatosis by reducing hepatic TG level (Cho et al., 2017), implying the potential effect of ATR on NAFLD treatment. Here, ATR is linked to Hepatic steatosis.